GSK plc Share Repurchase Program Update

GSK plc announced that on April 7, 2026, acting through BNP Paribas SA, it purchased 335,000 of its own ordinary shares. The purchases were made as part of the Company's ongoing buyback program. The lowest price paid per share was GBp 2,084.00, and the highest price was GBp 2,134.00, with a volume-weighted average price of GBp 2,113.08. These shares will be held as treasury shares. Since February 17, 2026, GSK has purchased a total of 17,236,521 ordinary shares. Following this transaction, the Company holds 257,127,615 ordinary shares in treasury and has 4,059,056,834 ordinary shares in issue. The total voting rights in the Company are 4,059,056,834, which shareholders can use for notification calculations. The percentage of voting rights held in treasury is 6.33%. Detailed trade information for the purchases made on April 7, 2026, across various trading venues is provided in the filing.